JP2025501646A5 - - Google Patents
Info
- Publication number
- JP2025501646A5 JP2025501646A5 JP2024539849A JP2024539849A JP2025501646A5 JP 2025501646 A5 JP2025501646 A5 JP 2025501646A5 JP 2024539849 A JP2024539849 A JP 2024539849A JP 2024539849 A JP2024539849 A JP 2024539849A JP 2025501646 A5 JP2025501646 A5 JP 2025501646A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- subject
- improved
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22150783.3 | 2022-01-10 | ||
| EP22150783.3A EP4209215A1 (en) | 2022-01-10 | 2022-01-10 | Treatment of gm2 gangliosidosis |
| EP22193136 | 2022-08-31 | ||
| EP22193136.3 | 2022-08-31 | ||
| PCT/EP2023/050459 WO2023131720A1 (en) | 2022-01-10 | 2023-01-10 | Treatment of gm2 gangliosidosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501646A JP2025501646A (ja) | 2025-01-22 |
| JP2025501646A5 true JP2025501646A5 (https=) | 2026-01-20 |
Family
ID=84982296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539849A Pending JP2025501646A (ja) | 2022-01-10 | 2023-01-10 | Ｇｍ２ガングリオシドーシスの処置 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250120958A1 (https=) |
| EP (2) | EP4714497A2 (https=) |
| JP (1) | JP2025501646A (https=) |
| AU (1) | AU2023205441A1 (https=) |
| CA (1) | CA3242701A1 (https=) |
| IL (1) | IL314212A (https=) |
| MX (1) | MX2024008583A (https=) |
| TW (1) | TW202337456A (https=) |
| WO (1) | WO2023131720A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202539666A (zh) * | 2024-02-01 | 2025-10-16 | 荷蘭商雅捷法羅斯公司 | Gm1神經節苷脂儲積症之治療 |
| EP4595964A1 (en) * | 2024-02-01 | 2025-08-06 | Azafaros B.V. | Treatment of gm1 gangliosidosis |
| WO2026013261A1 (en) | 2024-07-11 | 2026-01-15 | Azafaros B.V. | Nizubaglustat for use in the treatment of lysosomal storage disorders |
| EP4678174A1 (en) | 2024-07-11 | 2026-01-14 | Azafaros B.V. | Nizubaglustat for use in the treatment of lysosomal storage disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3461812B1 (en) | 2014-03-27 | 2021-10-13 | Academisch Medisch Centrum | N-(5-(biphen-4-ylmethyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase |
| EP3978474A1 (en) * | 2020-10-02 | 2022-04-06 | Azafaros B.V. | Crystalline forms of a pharmaceutical compound |
-
2023
- 2023-01-10 EP EP25220465.6A patent/EP4714497A2/en active Pending
- 2023-01-10 MX MX2024008583A patent/MX2024008583A/es unknown
- 2023-01-10 JP JP2024539849A patent/JP2025501646A/ja active Pending
- 2023-01-10 EP EP23700690.3A patent/EP4463157B1/en active Active
- 2023-01-10 IL IL314212A patent/IL314212A/en unknown
- 2023-01-10 US US18/727,631 patent/US20250120958A1/en active Pending
- 2023-01-10 CA CA3242701A patent/CA3242701A1/en active Pending
- 2023-01-10 AU AU2023205441A patent/AU2023205441A1/en active Pending
- 2023-01-10 TW TW112101050A patent/TW202337456A/zh unknown
- 2023-01-10 WO PCT/EP2023/050459 patent/WO2023131720A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025501646A5 (https=) | ||
| TWI336322B (en) | Substituted phenoxyacetic acids and pharmaceutical compositions and uses thereof | |
| TW200522941A (en) | Method for modulating calcium ion-release-activated calcium ion channels | |
| JP2021515083A5 (https=) | ||
| JPS6094970A (ja) | ２―アミノ―５―ヒドロキシ―４―メチルピリミジン誘導体 | |
| MX2009002422A (es) | Inhibidores bcl para tratar exceso de plaquetas. | |
| RU2749189C2 (ru) | Композиции и способы лечения ксеростомии | |
| EA028077B1 (ru) | N-(4-гидрокси-4-метилциклогексил)-4-фенилбензолсульфонамиды и n-(4-гидрокси-4-метилциклогексил)-4-(2-пиридил)бензолсульфонамиды и их терапевтическое применение | |
| RU2241707C2 (ru) | 1,4-замещенные пиперазины или 4-алкилиденилпиперидины, фармацевтическая композиция на их основе и способ лечения | |
| JPS61197554A (ja) | 新規アニリド | |
| RU2641293C2 (ru) | Бензофуразановые антимилоидные соединения и способы | |
| JPH02209848A (ja) | ナフチルメチルアミン誘導体およびそれを有効成分とする抗真菌剤 | |
| KR102679975B1 (ko) | 지방독성 손상을 저감하기 위한 화합물 | |
| CA1330446C (en) | Phenolic thioalkylamides as inhibitors of 5-lipoxygenase | |
| WO2024060911A1 (zh) | 苯并异噻唑化合物及其药物组合物和应用 | |
| CA2362554A1 (en) | Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity | |
| CA2364900A1 (en) | Polycyclic 2-amino-thiazole systems, method for the production thereof and medicament containing said compounds | |
| CA2383783A1 (en) | Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia | |
| GB2465796A (en) | Metformin for the therapeutic use of conditions with raised serum amyloid A levels | |
| JPH0141616B2 (https=) | ||
| KR20220007439A (ko) | 신규 나프토퀴논 유도체 화합물 및 이를 포함하는 항균용 조성물 | |
| EP0404233A2 (en) | Novel use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents | |
| JP5913293B2 (ja) | 芳香族ブタン−２−オール化合物ならびにその製造および使用 | |
| US6518312B2 (en) | Immune enhancement | |
| JP2007530594A (ja) | 炎症及び免疫に関連する用途に用いられるアクリロニトリル誘導体 |